POLYPOIDAL CHOROIDAL VASCULOPATHY
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy may offer better control for rare eye condition
Disease control CompletedThis study tested two treatments for polypoidal choroidal vasculopathy (PCV), an eye disease that can cause vision loss. 60 patients received either eye injections of aflibercept alone or aflibercept combined with a special laser treatment. The goal was to see which approach bett…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: NA • Sponsor: Singapore National Eye Centre • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Eye disease study tracks 5-Year recurrence and treatment patterns
Knowledge-focused CompletedThis study followed 72 people with Polypoidal Choroidal Vasculopathy (PCV), an eye condition that can cause vision loss, for 5 years after their first treatment. Researchers wanted to see how often the disease comes back, what treatments were needed over time, and whether early t…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated May 17, 2026 09:18 UTC